机构:[1]Beijing Visual Science and Translational Eye Research Institute (BERI), Eye Center of Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.[2]Institute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.[3]Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, USA.[4]Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA.[5]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital University of Medical Science, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院[6]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.[7]Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.[8]Rothschild Foundation Hospital, Institut Francais de Myopie, Paris, France.
The study was supported by National Natural Science Foundation of China (#82271086, #82388101).TYW declares consulting fees from Aldropika Therapeutics, Bayer, Boehringer
Ingelheim, Genentech, Iveric Bio, Novartis, Plano, Oxurion, Roche, Sanofi, and Shanghai Henlius;
funding from the National Key R&D Program, China (grant number 2022YFC2502800); and being an
inventor, patent holder, and cofounder of the start-up companies EyRiS and Visre.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|1 区医学
小类|1 区眼科学
最新[2025]版:
大类|1 区医学
小类|1 区眼科学
第一作者:
第一作者机构:[1]Beijing Visual Science and Translational Eye Research Institute (BERI), Eye Center of Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[1]Beijing Visual Science and Translational Eye Research Institute (BERI), Eye Center of Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.[6]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
推荐引用方式(GB/T 7714):
Chen Haichao,Pan Zhe,Liu Xinyu,et al.Posterior Eye Curvature as a Biomarker for Differentiating Pathologic Myopia from High Myopia[J].American Journal Of Ophthalmology.2025,doi:10.1016/j.ajo.2025.03.024.
APA:
Chen Haichao,Pan Zhe,Liu Xinyu,Xie Hui,Zaman Fahim Ahmed...&Wang Ya Xing.(2025).Posterior Eye Curvature as a Biomarker for Differentiating Pathologic Myopia from High Myopia.American Journal Of Ophthalmology,,
MLA:
Chen Haichao,et al."Posterior Eye Curvature as a Biomarker for Differentiating Pathologic Myopia from High Myopia".American Journal Of Ophthalmology .(2025)